KNSA
Kiniksa Pharmaceuticals Ltd
NASDAQ: KNSA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.99
-1.60% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.23
P/S ratio
6.02x
EPS (TTM)
$0.91
Dividend yield
—
52W range
$25 – $54
Volume
0.8M
Kiniksa Pharmaceuticals Ltd (KNSA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $7.70M | $38.54M | $220.18M | $270.26M | $423.24M | $677.56M |
| Revenue growth (YoY) | — | — | — | — | — | +400.3% | +471.2% | +22.7% | +56.6% | +60.1% |
| Cost of revenue | $22000.00 | $28000.00 | $286000.00 | $3.28M | $3.81M | $9.10M | $22.89M | $56.52M | $60.91M | $307.41M |
| Gross profit | $-22000.00 | $-28000.00 | $-286000.00 | $-3.28M | $-3.81M | $29.44M | $197.28M | $213.74M | $362.33M | $370.15M |
| Gross margin | — | — | — | — | -49.4% | 76.4% | 89.6% | 79.1% | 85.6% | 54.6% |
| R&D | $17.44M | $56.36M | $86.60M | $135.00M | $112.04M | $99.30M | $65.49M | $76.10M | $111.62M | $96.85M |
| SG&A | $6.56M | $9.04M | $21.56M | $34.96M | $45.32M | $85.95M | $97.95M | $119.90M | $156.58M | $196.27M |
| Operating income | $-24.00M | $-65.40M | $-108.16M | $-169.96M | $-157.36M | $-156.64M | $9.77M | $-25.20M | $-45.62M | $77.22M |
| Operating margin | — | — | — | — | -2042.6% | -406.4% | 4.4% | -9.3% | -10.8% | 11.4% |
| EBITDA | $-23.98M | $-65.37M | $-107.87M | $-167.90M | $-154.96M | $-154.28M | $12.18M | $-22.86M | $-43.92M | $90.42M |
| EBITDA margin | — | — | — | — | -2011.4% | -400.3% | 5.5% | -8.5% | -10.4% | 13.3% |
| EBIT | $-24.00M | $-65.40M | $-108.16M | $-169.96M | $-157.36M | $-156.64M | $9.77M | $-25.20M | $-45.62M | $88.87M |
| Interest expense | $0.00 | $0.00 | $0.00 | $8.12M | $3.54M | $2.45M | $1.25M | — | — | — |
| Income tax | $36000.00 | $2000.00 | $-214000.00 | $-2.05M | $5.15M | $1.39M | $-172.34M | $-30.74M | $7.04M | — |
| Effective tax rate | -0.2% | -0.0% | 0.2% | 1.2% | -3.3% | -0.9% | -1563.0% | 184.6% | -19.5% | 0.0% |
| Net income | $-23.97M | $-64.87M | $-103.23M | $-161.87M | $-161.38M | $-157.92M | $183.36M | $14.08M | $-43.19M | $59.01M |
| Net income growth (YoY) | — | -170.6% | -59.1% | -56.8% | +0.3% | +2.1% | +216.1% | -92.3% | -406.7% | +236.6% |
| Profit margin | — | — | — | — | -2094.8% | -409.7% | 83.3% | 5.2% | -10.2% | 8.7% |